Stockscreener 앱 받기
23.30
22.12%
4.22
시간 외 거래:
23.29
-0.01
-0.04%
전일 마감가:
$19.08
열려 있는:
$20.74
하루 거래량:
516.87K
Relative Volume:
1.40
시가총액:
$1.59B
수익:
$751.00K
순이익/손실:
$-74.57M
주가수익비율:
-21.12
EPS:
-1.1031
순현금흐름:
$-54.46M
1주 성능:
+24.93%
1개월 성능:
+24.80%
6개월 성능:
+55.33%
1년 성능:
+38.77%
1일 변동 폭
$20.74
$23.45
1주일 범위
$18.36
$23.45
52주 변동 폭
$12.56
$26.30
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
23.30 | 1.30B | 751.00K | -74.57M | -54.46M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 개시 | Mizuho | Outperform |
| 2025-07-07 | 개시 | Oppenheimer | Outperform |
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Pulse Bio rises after over $13M insider buying - MSN
Pulse Biosciences (PLSE) Stock Soars After Insider Buying - GuruFocus
Pulse Biosciences stock (US73242P1030): CEO buys $295K in shares - AD HOC NEWS
Pulse Biosciences (PLSE) Stock Surges 17% on Major $13M Insider Purchase - MEXC
Pulse Biosciences (PLSE) Stock Jumps 17% After $13M Insider Buy - MEXC Exchange
Pulse Biosciences (PLSE) Co-Chairmen Invest $13.3M in Company St - GuruFocus
Pulse Biosciences stock jumps after insiders buy $13.3M in shares - Investing.com
Pulse Biosciences stock jumps after insiders buy $13.3M in shares By Investing.com - Investing.com South Africa
Pulse Bio rises after over $13M insider buying (PLSE:NASDAQ) - Seeking Alpha
Pulse Biosciences insiders buy $13.3 million in stock By Investing.com - Investing.com Australia
Pulse Biosciences insiders buy $13.3 million in stock - Investing.com
ATM equity purchases by Pulse Biosciences' co-chairmen total approximately $13.3 million - marketscreener.com
ATM Equity Purchases By Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million - TradingView
$13.3M insider stock buy: Pulse Biosciences chiefs add 675K shares - Stock Titan
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million - The Joplin Globe
Pulse Biosciences Insider Bought Shares Worth $12,999,988, According to a Recent SEC Filing - Moomoo
Pulse Biosciences Insider Bought Shares Worth $295,350, According to a Recent SEC Filing - marketscreener.com
Insider Buying: Paul Laviolette Acquires 15,000 Shares of Pulse Biosciences Inc (PLSE) - GuruFocus
Pulse Biosciences CEO Paul LaViolette acquires $295,350 in shares - Investing.com UK
Pulse Biosciences CEO Paul LaViolette acquires $295,350 in shares By Investing.com - Investing.com Australia
Pulse Biosciences (NASDAQ: PLSE) CEO adds 15,000 shares in open-market buy - Stock Titan
Pulse Biosciences CEO Paul Laviolette buys $295,350 in company stock By Investing.com - Investing.com Australia
Pulse Biosciences CEO Paul Laviolette buys $295,350 in company stock - Investing.com UK
Pulse Biosciences director Robert Duggan buys $13 million in shares By Investing.com - Investing.com Nigeria
Pulse Biosciences director Robert Duggan buys $13 million in shares - Investing.com UK
Pulse Biosciences 10% Owner Purchased Shares Worth Over $12M - TradingView
[Form 4] PULSE BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Robert Duggan adds 660K Pulse Biosciences (PLSE) shares in open-market buy - Stock Titan
Major holder controls 71.6% as Pulse Biosciences (NASDAQ: PLSE) outlines 2026 vote - Stock Titan
Number of shareholders of Pulse Biosciences, Inc – NASDAQ:PLSE - TradingView
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation? - Yahoo Finance
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2026 Earnings Call Transcript - Insider Monkey
Pulse Biosciences (PLSE) upgraded to buy: What does it mean for the stock? - MSN
Pulse Biosciences Races Ahead on AF Trial Momentum - TipRanks
Pulse Biosciences Q1 Earnings Call Highlights - Yahoo Finance
MSN Money - MSN
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference - BioSpace
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - Quantisnow
Earnings call transcript: Pulse Biosciences Q1 2026 EPS beats, stock drops - Investing.com UK
(PLSE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Earnings call transcript: Pulse Biosciences Q1 2026 EPS beats, stock drops By Investing.com - Investing.com South Africa
Q1 2026 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo! Finance Canada
Pulse Biosciences 1Q Loss/Shr 27c >PLSE - Moomoo
Pulse Biosciences Authorizes Insider Purchases Under Equity Program - TipRanks
Pulse Biosciences board approves affiliate participation in equity sales program - Investing.com Australia
Pulse Biosciences board approves affiliate participation in equity sales program By Investing.com - Investing.com South Africa
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):